ReP USP - Resultado da busca

Artigo de periodico
UHMK1 is a novel splicing regulatory kinase (2023)
Arfelli, Vanessa Cristina; Chang, Yun-Chien; Bagnoli, Johannes W.; Kerbs, Paul; Ciamponi, Felipe E.; Paz, Laissa Mayara da Silva; Pankivskyi, Serhii; Salone, Jean de Matha; Maucuer, Alexandre; Massirer, Katlin B.; Enard, Wolfgang; Kuster, Bernhard; Greif, Philipp A.; Archangelo, Leticia Fröhlich
Source: Journal of Biological Chemistry. Unidade: FMRP
Subjects: PROTEÍNAS QUINASES, RNA, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARFELLI, Vanessa Cristina et al. UHMK1 is a novel splicing regulatory kinase. Journal of Biological Chemistry, v. 299, n. 4, p. 1-22, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jbc.2023.103041. Acesso em: 02 out. 2024.
APA
Arfelli, V. C., Chang, Y. -C., Bagnoli, J. W., Kerbs, P., Ciamponi, F. E., Paz, L. M. da S., et al. (2023). UHMK1 is a novel splicing regulatory kinase. Journal of Biological Chemistry, 299( 4), 1-22. doi:10.1016/j.jbc.2023.103041
NLM
Arfelli VC, Chang Y-C, Bagnoli JW, Kerbs P, Ciamponi FE, Paz LM da S, Pankivskyi S, Salone J de M, Maucuer A, Massirer KB, Enard W, Kuster B, Greif PA, Archangelo LF. UHMK1 is a novel splicing regulatory kinase [Internet]. Journal of Biological Chemistry. 2023 ; 299( 4): 1-22.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.jbc.2023.103041
Vancouver
Arfelli VC, Chang Y-C, Bagnoli JW, Kerbs P, Ciamponi FE, Paz LM da S, Pankivskyi S, Salone J de M, Maucuer A, Massirer KB, Enard W, Kuster B, Greif PA, Archangelo LF. UHMK1 is a novel splicing regulatory kinase [Internet]. Journal of Biological Chemistry. 2023 ; 299( 4): 1-22.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.jbc.2023.103041
Parte de monografia/livro
Alternative splicing of pre-messenger RNA (2022)
Arfelli, Vanessa Cristina; Archangelo, Leticia Fröhlich
Source: Transcriptomics in health and disease. Unidade: FMRP
Subjects: GENES, SEQUENCIAMENTO GENÉTICO, PROTEÔMICA, EXPRESSÃO GÊNICA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARFELLI, Vanessa Cristina e ARCHANGELO, Leticia Fröhlich. Alternative splicing of pre-messenger RNA. Transcriptomics in health and disease. Tradução . Cham: Springer, 2022. . Disponível em: https://doi.org/10.1007/978-3-030-87821-4_2. Acesso em: 02 out. 2024.
APA
Arfelli, V. C., & Archangelo, L. F. (2022). Alternative splicing of pre-messenger RNA. In Transcriptomics in health and disease. Cham: Springer. doi:10.1007/978-3-030-87821-4_2
NLM
Arfelli VC, Archangelo LF. Alternative splicing of pre-messenger RNA [Internet]. In: Transcriptomics in health and disease. Cham: Springer; 2022. [citado 2024 out. 02 ] Available from: https://doi.org/10.1007/978-3-030-87821-4_2
Vancouver
Arfelli VC, Archangelo LF. Alternative splicing of pre-messenger RNA [Internet]. In: Transcriptomics in health and disease. Cham: Springer; 2022. [citado 2024 out. 02 ] Available from: https://doi.org/10.1007/978-3-030-87821-4_2
Artigo de periodico
PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response (2022)
Serafim, Rodolfo Bortolozo; Cardoso, Cibele; Arfelli, Vanessa Cristina; Valente, Valeria; Archangelo, Leticia Fröhlich
Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Unidade: FMRP
Subjects: ANTINEOPLÁSICOS, LINHAGEM CELULAR, DANO AO DNA, GLIOMA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAFIM, Rodolfo Bortolozo et al. PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, v. 1868, p. 166382, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbadis.2022.166382. Acesso em: 02 out. 2024.
APA
Serafim, R. B., Cardoso, C., Arfelli, V. C., Valente, V., & Archangelo, L. F. (2022). PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1868, 166382. doi:10.1016/j.bbadis.2022.166382
NLM
Serafim RB, Cardoso C, Arfelli VC, Valente V, Archangelo LF. PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response [Internet]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2022 ; 1868 166382.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.bbadis.2022.166382
Vancouver
Serafim RB, Cardoso C, Arfelli VC, Valente V, Archangelo LF. PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response [Internet]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2022 ; 1868 166382.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.bbadis.2022.166382
Trabalho de evento-resumo
Identificação, clonagem e ensaios de localização subcelular de mutações associadas a câncer na proteína Splicing Factor 1 (SF1) (2019)
Oliveira, Lucca Zaghi de; Rocha, Viviana Loureiro; Archangelo, Leticia Fröhlich
Source: Resumos. Conference titles: Simpósio Internacional de Iniciação Científica e Tecnológica da USP (SIICUSP). Unidades: FMRP, FFCLRP
Subjects: PROTEÍNAS, MUTAÇÃO GENÉTICA, NEOPLASIAS, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Lucca Zaghi de e ROCHA, Viviana Loureiro e ARCHANGELO, Leticia Fröhlich. Identificação, clonagem e ensaios de localização subcelular de mutações associadas a câncer na proteína Splicing Factor 1 (SF1). 2019, Anais.. Ribeirão Preto: FMRP-USP, 2019. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 02 out. 2024.
APA
Oliveira, L. Z. de, Rocha, V. L., & Archangelo, L. F. (2019). Identificação, clonagem e ensaios de localização subcelular de mutações associadas a câncer na proteína Splicing Factor 1 (SF1). In Resumos. Ribeirão Preto: FMRP-USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Oliveira LZ de, Rocha VL, Archangelo LF. Identificação, clonagem e ensaios de localização subcelular de mutações associadas a câncer na proteína Splicing Factor 1 (SF1) [Internet]. Resumos. 2019 ;[citado 2024 out. 02 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Oliveira LZ de, Rocha VL, Archangelo LF. Identificação, clonagem e ensaios de localização subcelular de mutações associadas a câncer na proteína Splicing Factor 1 (SF1) [Internet]. Resumos. 2019 ;[citado 2024 out. 02 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Trabalho de evento-resumo
Identification, cloning and preliminary studies of the cancer-related mutations found in the splicing factor 1 (SF1) (2019)
Oliveira, Lucca Zaghi de; Rocha, Viviana Loureiro; Archangelo, Leticia Fröhlich
Source: Resumos. Conference titles: International Symposium on Translational Oncology. Unidades: FMRP, FFCLRP
Subjects: NEOPLASIAS, MUTAÇÃO GENÉTICA, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Lucca Zaghi de e ROCHA, Viviana Loureiro e ARCHANGELO, Leticia Fröhlich. Identification, cloning and preliminary studies of the cancer-related mutations found in the splicing factor 1 (SF1). 2019, Anais.. Barretos: Hospital do Câncer de Barretos, 2019. . Acesso em: 02 out. 2024.
APA
Oliveira, L. Z. de, Rocha, V. L., & Archangelo, L. F. (2019). Identification, cloning and preliminary studies of the cancer-related mutations found in the splicing factor 1 (SF1). In Resumos. Barretos: Hospital do Câncer de Barretos.
NLM
Oliveira LZ de, Rocha VL, Archangelo LF. Identification, cloning and preliminary studies of the cancer-related mutations found in the splicing factor 1 (SF1). Resumos. 2019 ;[citado 2024 out. 02 ]
Vancouver
Oliveira LZ de, Rocha VL, Archangelo LF. Identification, cloning and preliminary studies of the cancer-related mutations found in the splicing factor 1 (SF1). Resumos. 2019 ;[citado 2024 out. 02 ]
Artigo de periodico-carta/editorial
Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] (2019)
Campos, Lívia Weijenborg; Zenatti, Priscila Pini ; Pissinato, Leonardo Granato ; Rodrigues, Gisele Olinto Libanio; Artico, Leonardo Luís ; Guimarães, Thais Rafael; Archangelo, Leticia Fröhlich ; Martínez, Leandro ; Brooks, Andrew J.; Yunes, Jose Andres
Source: Blood. Unidade: FMRP
Subjects: ONCOGENES, AMINOÁCIDOS, HIPERSENSIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Lívia Weijenborg et al. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2018-09-872945. Acesso em: 02 out. 2024. , 2019
APA
Campos, L. W., Zenatti, P. P., Pissinato, L. G., Rodrigues, G. O. L., Artico, L. L., Guimarães, T. R., et al. (2019). Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2018-09-872945
NLM
Campos LW, Zenatti PP, Pissinato LG, Rodrigues GOL, Artico LL, Guimarães TR, Archangelo LF, Martínez L, Brooks AJ, Yunes JA. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] [Internet]. Blood. 2019 ; 133( 11): 1259-1263.[citado 2024 out. 02 ] Available from: https://doi.org/10.1182/blood-2018-09-872945
Vancouver
Campos LW, Zenatti PP, Pissinato LG, Rodrigues GOL, Artico LL, Guimarães TR, Archangelo LF, Martínez L, Brooks AJ, Yunes JA. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] [Internet]. Blood. 2019 ; 133( 11): 1259-1263.[citado 2024 out. 02 ] Available from: https://doi.org/10.1182/blood-2018-09-872945
Trabalho de evento-resumo
Effect of Uhmk1 overexpression and knockdown in murine cells (2018)
Arfelli, Vanessa Cristina; Paz, Laissa Mayara da Silva; Archangelo, Leticia Fröhlich
Source: Abstracts. Conference titles: Congress of The Brazilian Society for Cell Biology. Unidade: FMRP
Subjects: RNA, ENZIMAS CELULOLÍTICAS, GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARFELLI, Vanessa Cristina e PAZ, Laissa Mayara da Silva e ARCHANGELO, Leticia Fröhlich. Effect of Uhmk1 overexpression and knockdown in murine cells. 2018, Anais.. São Paulo: SBBC, 2018. Disponível em: http://www.sbbc.org.br/wp-content/uploads/2014/08/Livro-ResumosSBBC2018.pdf. Acesso em: 02 out. 2024.
APA
Arfelli, V. C., Paz, L. M. da S., & Archangelo, L. F. (2018). Effect of Uhmk1 overexpression and knockdown in murine cells. In Abstracts. São Paulo: SBBC. Recuperado de http://www.sbbc.org.br/wp-content/uploads/2014/08/Livro-ResumosSBBC2018.pdf
NLM
Arfelli VC, Paz LM da S, Archangelo LF. Effect of Uhmk1 overexpression and knockdown in murine cells [Internet]. Abstracts. 2018 ;[citado 2024 out. 02 ] Available from: http://www.sbbc.org.br/wp-content/uploads/2014/08/Livro-ResumosSBBC2018.pdf
Vancouver
Arfelli VC, Paz LM da S, Archangelo LF. Effect of Uhmk1 overexpression and knockdown in murine cells [Internet]. Abstracts. 2018 ;[citado 2024 out. 02 ] Available from: http://www.sbbc.org.br/wp-content/uploads/2014/08/Livro-ResumosSBBC2018.pdf
Artigo de periodico
UHMK1 (U2AF homology motif kinase 1) (2018)
Arfelli, Vanessa Cristina; Archangelo, Leticia Fröhlich
Source: Atlas of Genetics and Cytogenetics in Oncology and Haematology. Unidade: FMRP
Subjects: CROMOSSOMOS, GENÉTICA MÉDICA, CICLO CELULAR, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARFELLI, Vanessa Cristina e ARCHANGELO, Leticia Fröhlich. UHMK1 (U2AF homology motif kinase 1). Atlas of Genetics and Cytogenetics in Oncology and Haematology, v. 22, n. 8, p. 328-335, 2018Tradução . . Disponível em: https://doi.org/10.4267/2042/68931. Acesso em: 02 out. 2024.
APA
Arfelli, V. C., & Archangelo, L. F. (2018). UHMK1 (U2AF homology motif kinase 1). Atlas of Genetics and Cytogenetics in Oncology and Haematology, 22( 8), 328-335. doi:10.4267/2042/68931
NLM
Arfelli VC, Archangelo LF. UHMK1 (U2AF homology motif kinase 1) [Internet]. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2018 ; 22( 8): 328-335.[citado 2024 out. 02 ] Available from: https://doi.org/10.4267/2042/68931
Vancouver
Arfelli VC, Archangelo LF. UHMK1 (U2AF homology motif kinase 1) [Internet]. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2018 ; 22( 8): 328-335.[citado 2024 out. 02 ] Available from: https://doi.org/10.4267/2042/68931
Artigo de periodico
The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation (2018)
Barbutti, Isabella; Machado Neto, João Agostinho ; Arfelli, Vanessa Cristina; Campos, Paula de Melo; Traina, Fabiola; Saad, Sara Teresinha Olalla; Archangelo, Leticia Fröhlich
Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Unidade: FMRP
Subjects: LEUCEMIA, HEMATOPOESE, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBUTTI, Isabella et al. The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, v. 1864, n. 3, p. 959-966, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.bbadis.2018.01.004. Acesso em: 02 out. 2024.
APA
Barbutti, I., Machado Neto, J. A., Arfelli, V. C., Campos, P. de M., Traina, F., Saad, S. T. O., & Archangelo, L. F. (2018). The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1864( 3), 959-966. doi:10.1016/j.bbadis.2018.01.004
NLM
Barbutti I, Machado Neto JA, Arfelli VC, Campos P de M, Traina F, Saad STO, Archangelo LF. The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation [Internet]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018 ; 1864( 3): 959-966.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.bbadis.2018.01.004
Vancouver
Barbutti I, Machado Neto JA, Arfelli VC, Campos P de M, Traina F, Saad STO, Archangelo LF. The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation [Internet]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018 ; 1864( 3): 959-966.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.bbadis.2018.01.004
Trabalho de evento-resumo
Characterization of the PICALM interacting mitotic regulator (PIMREG) as a molecular marker of tumor progression in LGG and GBM (2018)
Serafim, Rodolfo Bortolozo; Arfelli, Vanessa Cristina; Valente, Valéria; Archangelo, Leticia Fröhlich
Source: Abstracts. Conference titles: Annual Meeting of American Society for Cell Biology and European Molecular Biology Organization (ASCB/EMBO). Unidade: FMRP
Subjects: MARCADOR MOLECULAR, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAFIM, Rodolfo Bortolozo et al. Characterization of the PICALM interacting mitotic regulator (PIMREG) as a molecular marker of tumor progression in LGG and GBM. 2018, Anais.. San Diego: ASCB/EMBO, 2018. Disponível em: https://ascb-embo2018.ascb.org/wp-content/uploads/sites/11/2018/11/PosterAbstracts2018.pdf. Acesso em: 02 out. 2024.
APA
Serafim, R. B., Arfelli, V. C., Valente, V., & Archangelo, L. F. (2018). Characterization of the PICALM interacting mitotic regulator (PIMREG) as a molecular marker of tumor progression in LGG and GBM. In Abstracts. San Diego: ASCB/EMBO. Recuperado de https://ascb-embo2018.ascb.org/wp-content/uploads/sites/11/2018/11/PosterAbstracts2018.pdf
NLM
Serafim RB, Arfelli VC, Valente V, Archangelo LF. Characterization of the PICALM interacting mitotic regulator (PIMREG) as a molecular marker of tumor progression in LGG and GBM [Internet]. Abstracts. 2018 ;[citado 2024 out. 02 ] Available from: https://ascb-embo2018.ascb.org/wp-content/uploads/sites/11/2018/11/PosterAbstracts2018.pdf
Vancouver
Serafim RB, Arfelli VC, Valente V, Archangelo LF. Characterization of the PICALM interacting mitotic regulator (PIMREG) as a molecular marker of tumor progression in LGG and GBM [Internet]. Abstracts. 2018 ;[citado 2024 out. 02 ] Available from: https://ascb-embo2018.ascb.org/wp-content/uploads/sites/11/2018/11/PosterAbstracts2018.pdf
Artigo de periodico
PIMREG (PICALM interacting mitotic regulator) (2017)
Archangelo, Leticia Fröhlich
Source: Atlas of Genetics and Cytogenetics in Oncology and Haematology. Unidade: FMRP
Subjects: CROMOSSOMOS, GENÉTICA MÉDICA, CICLO CELULAR, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARCHANGELO, Leticia Fröhlich. PIMREG (PICALM interacting mitotic regulator). Atlas of Genetics and Cytogenetics in Oncology and Haematology, v. 21, n. 10, p. 358-362, 2017Tradução . . Disponível em: https://doi.org/10.4267/2042/68737. Acesso em: 02 out. 2024.
APA
Archangelo, L. F. (2017). PIMREG (PICALM interacting mitotic regulator). Atlas of Genetics and Cytogenetics in Oncology and Haematology, 21( 10), 358-362. doi:10.4267/2042/68737
NLM
Archangelo LF. PIMREG (PICALM interacting mitotic regulator) [Internet]. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2017 ; 21( 10): 358-362.[citado 2024 out. 02 ] Available from: https://doi.org/10.4267/2042/68737
Vancouver
Archangelo LF. PIMREG (PICALM interacting mitotic regulator) [Internet]. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2017 ; 21( 10): 358-362.[citado 2024 out. 02 ] Available from: https://doi.org/10.4267/2042/68737
Artigo de periodico
CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells (2016)
Barbutti, Isabella; Xavier-Ferrucio, Juliana M.; Machado Neto, João Agostinho ; Ricon, Lauremilia; Traina, Fabiola; Bohlander, Stefan K.; Saad, Sara Teresinha Olalla; Archangelo, Leticia Fröhlich
Source: Oncotarget. Unidade: FMRP
Subjects: LEUCEMIA, PROLIFERAÇÃO CELULAR, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBUTTI, Isabella et al. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells. Oncotarget, v. 7, n. 42, p. 68385-68396, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.11724. Acesso em: 02 out. 2024.
APA
Barbutti, I., Xavier-Ferrucio, J. M., Machado Neto, J. A., Ricon, L., Traina, F., Bohlander, S. K., et al. (2016). CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells. Oncotarget, 7( 42), 68385-68396. doi:10.18632/oncotarget.11724
NLM
Barbutti I, Xavier-Ferrucio JM, Machado Neto JA, Ricon L, Traina F, Bohlander SK, Saad STO, Archangelo LF. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells [Internet]. Oncotarget. 2016 ; 7( 42): 68385-68396.[citado 2024 out. 02 ] Available from: https://doi.org/10.18632/oncotarget.11724
Vancouver
Barbutti I, Xavier-Ferrucio JM, Machado Neto JA, Ricon L, Traina F, Bohlander SK, Saad STO, Archangelo LF. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells [Internet]. Oncotarget. 2016 ; 7( 42): 68385-68396.[citado 2024 out. 02 ] Available from: https://doi.org/10.18632/oncotarget.11724

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration